GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novo Nordisk AS (WBO:NNO2) » Definitions » Other Gross PPE

Novo Nordisk AS (WBO:NNO2) Other Gross PPE : €9,696 Mil (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Novo Nordisk AS Other Gross PPE?

Novo Nordisk AS's Other Gross PPE for the quarter that ended in Dec. 2024 was €9,696 Mil.

Novo Nordisk AS's quarterly Other Gross PPE increased from Jun. 2024 (€14,736 Mil) to Sep. 2024 (€16,072 Mil) but then declined from Sep. 2024 (€16,072 Mil) to Dec. 2024 (€9,696 Mil).

Novo Nordisk AS's annual Other Gross PPE increased from Dec. 2022 (€6,925 Mil) to Dec. 2023 (€7,777 Mil) and increased from Dec. 2023 (€7,777 Mil) to Dec. 2024 (€9,696 Mil).


Novo Nordisk AS Other Gross PPE Historical Data

The historical data trend for Novo Nordisk AS's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novo Nordisk AS Other Gross PPE Chart

Novo Nordisk AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,966.00 6,569.52 6,924.78 7,777.49 9,695.76

Novo Nordisk AS Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,777.49 13,174.09 14,735.70 16,071.54 9,695.76

Novo Nordisk AS Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Novo Nordisk AS Business Description

Address
Novo Alle 1, Bagsvaerd, DNK, 2880
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk AS Headlines

No Headlines